AS-IV (200 mg/kg/day) alleviated isoproterenol-induced cardiac fibrosis in BALB/c mice by inhibiting the NLRP3 inflammasome pathway (Wan et al., 2018), indicating that AS-IV improves myocardial fibrosis by inhibiting inflammation. Here, NLRP3 is linked to Myocardial fibrosis.